• Return to Headlines

Exact Sciences Up 23.8% Since SmarTrend Uptrend Call (EXAS)

By James Quinn

SmarTrend identified an Uptrend for Exact Sciences (NASDAQ:EXAS) on August 22nd, 2018 at $62.65. In approximately 3 weeks, Exact Sciences has returned 23.76% as of today's recent price of $77.53.

Over the past year, Exact Sciences has traded in a range of $9.91 to $78.95 and is now at $77.53, 682% above that low. In the last five trading sessions, the 50-day moving average (MA) has climbed 2.0% while the 200-day MA has risen 0.6%.

Exact Sciences Corp., is focused on developing and commercializing a non-invasive molecular screening test for the early detection and prevention of colorectal cancer. The Company's test is a stool-based DNA test that identifies both pre-cancer and cancer by detecting genetic mutations in colorectal cancer cells.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Exact Sciences shares.

Log in and add Exact Sciences (EXAS) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights exact sciences

Ticker(s): EXAS